The ICB commissions several services from Community Pharmacy
For further information e-mail the medicines optimisation team bnssg.medicines-optimisation@nhs.net
Pharmacy First - NHS England » Launch of NHS Pharmacy First advanced service
Emergency Prescriptions
Patients requiring an urgent supply of repeat medication will need to contact NHS111 by telephone or online Emergency prescriptions – NHS 111. NHS 111 will then direct them to a pharmacy (or an urgent care centre if appropriate). If the medicine is supplied, they will be charged the relevant prescription charge unless they are eligible for free prescriptions.
Please do not send patients directly to a community pharmacy within surgery opening hours. If practices cannot support an urgent supply of a medicine please ask the patient to ring NHS111 or use the online service.
Please remind patients to order their repeat medication in plenty of time to give practices and pharmacy time to process their prescriptions and where possible order via the NHS App.
Electronic Prescription Service (EPS)
Electronic Repeat Dispensing (eRD)
This webpage is for Community Pharmacists and their teams based in Cornwall & Isles of Scilly, Devon, Bristol, Dorset, North Somerset, Somerset and South Gloucestershire.
Please remember to report any controlled drug incidents or concerns to the Controlled Drug Accountable Officer
Darren Barnett - Interim Controlled Drugs Accountable Officer NHS England South West
Tel: 07718 130 490
Controlled Drug incident reporting: www.cdreporting.co.uk
Controlled drug general queries email: england.southwestcontrolleddrugs@nhs.net
For further information: NHS England — South West » Controlled drugs
Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.
Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.